These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection. Schulze T, Mucke J, Markwardt J, Schlag PM, Bembenek A. J Surg Oncol; 2006 Feb 01; 93(2):109-19. PubMed ID: 16425290 [Abstract] [Full Text] [Related]
7. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy. Kim KJ, Huh SJ, Yang JH, Park W, Nam SJ, Kim JH, Lee JH, Kang SS, Lee JE, Kang MK, Park YJ, Nam HR. Jpn J Clin Oncol; 2005 Mar 01; 35(3):126-33. PubMed ID: 15741302 [Abstract] [Full Text] [Related]
9. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients. Gipponi M, Bassetti C, Canavese G, Catturich A, Di Somma C, Vecchio C, Nicolò G, Schenone F, Tomei D, Cafiero F. J Surg Oncol; 2004 Mar 01; 85(3):102-11. PubMed ID: 14991881 [Abstract] [Full Text] [Related]
10. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients? Marrazzo A, Taormina P, Gebbiab V, David M, Riili I, Lo Gerfo D, Casà L, Noto A. Chir Ital; 2007 Mar 01; 59(5):693-9. PubMed ID: 18019642 [Abstract] [Full Text] [Related]
11. Determinants of axillary recurrence after axillary lymph node dissection for invasive breast cancer. Voogd AC, de Boer R, van der Sangen MJ, Roumen RM, Rutten HJ, Coebergh JW. Eur J Surg Oncol; 2001 Apr 01; 27(3):250-5. PubMed ID: 11373100 [Abstract] [Full Text] [Related]
12. Factors affecting axillary lymph node retrieval and assessment in breast cancer patients. Cil T, Hauspy J, Kahn H, Gardner S, Melnick W, Flynn C, Holloway CM. Ann Surg Oncol; 2008 Dec 01; 15(12):3361-8. PubMed ID: 18830666 [Abstract] [Full Text] [Related]
13. Variability in axillary lymph node dissection for breast cancer. Schaapveld M, Otter R, de Vries EG, Fidler V, Grond JA, van der Graaf WT, de Vogel PL, Willemse PH. J Surg Oncol; 2004 Jul 15; 87(1):4-12. PubMed ID: 15221913 [Abstract] [Full Text] [Related]
15. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer. Palesty JA, Foster JM, Hurd TC, Watroba N, Rezaishiraz H, Edge SB. J Surg Oncol; 2006 Feb 01; 93(2):129-32. PubMed ID: 16425295 [Abstract] [Full Text] [Related]
16. Axillary biopsy compared with dissection in the staging of lymph nodes in operable breast cancer. A randomised trial. Christensen SB, Jansson C. Eur J Surg; 1993 Mar 01; 159(3):159-62. PubMed ID: 8102890 [Abstract] [Full Text] [Related]
17. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005). Chen AY, Halpern MT, Schrag NM, Stewart A, Leitch M, Ward E. J Natl Cancer Inst; 2008 Apr 02; 100(7):462-74. PubMed ID: 18364506 [Abstract] [Full Text] [Related]
20. Variation in management of early breast cancer in the Netherlands, 2003-2006. van Steenbergen LN, van de Poll-Franse LV, Wouters MW, Jansen-Landheer ML, Coebergh JW, Struikmans H, Tjan-Heijnen VC, van de Velde CJ. Eur J Surg Oncol; 2010 Sep 02; 36 Suppl 1():S36-43. PubMed ID: 20620013 [Abstract] [Full Text] [Related] Page: [Next] [New Search]